EUVIMEDEUVIMED entdecken
Crossref

Influence of TPMT and NUDT15 Genetic Polymorphisms on Mercaptopurine Pharmacokinetics in Healthy Volunteers

Qihui Kong, Qiqi Zhang, Di Chen, Jinfang Lou, Jian Zhu, Mingjing Chen, Ting Li iD

Genetic Testing and Molecular Biomarkers · 2024

DOI: 10.1089/gtmb.2023.0605 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetic Testing and Molecular Biomarkers, 2024. Verfasst von Qihui Kong und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Mercaptopurine, Methyltransferases, Pyrophosphatases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study aimed to investigate the impact of genetic polymorphisms of thiopurine methyltransferase (TPMT) and NUDT15 on pharmacokinetics profile of mercaptopurine in healthy adults in China.

Methods

Blood samples were obtained from 45 healthy adult volunteers who were administered azathioprine. Genomic DNA was extracted and sequenced for TPMT and NUDT15. The plasma concentrations of 6-mercaptopurine (6-MP) were determined by ultra-performance liquid chromatography-tandem mass spectrometry. Finally, pharmacokinetic parameters were calculated based on the time-concentration curve.

Results

Among the 45 healthy adult volunteers enrolled in the study, two TPMT allelic variants and three NUDT15 allelic variants were detected. In total, six genotypes were identified, including TPMT*1/*1&NUDT15*1/*1, TPMT*1/*1&NUDT15*1/*2, TPMT*1/*1&NUDT15*1/*9, TPMT*1/*1&NUDT15*2/*5, TPMT*1/*6&NUDT15*1/*2, and TPMT*1/*3&NUDT15*1/*2. The results indicated that Area Under Curve (AUC) of 6-MP in volunteers with TPMT*1/*3&NUDT15*1/*2 and TPMT*1/*6&NUDT15*1/*2 were 1.57-1.62-fold higher than in individuals carrying the wild type (TPMT*1/*1&NUDT15*1/*1). Compared with wild type, the half-life (T1/2) of TPMT*1/*6&NUDT15*1/*2 was extended by 1.98 times, whereas T1/2 of TPMT*1/*3&NUDT15*1/*2 decreased by 67%. The maximum concentration (Cmax) of TPMT*1/*3&NUDT15*1/*2 increased significantly by 2.15-fold, whereas the corresponding clearance (CL/F) decreased significantly by 58.75%.

Conclusion

The findings of this study corroborate the notion that various genotypes of TPMT and NUDT15 can impact the pharmacokinetics of mercaptopurine, potentially offering foundational insights for personalized mercaptopurine therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MercaptopurineMethyltransferasesPyrophosphatasesAdultFemaleHumansMaleMiddle AgedYoung AdultAllelesAzathioprineChinaGenotypeHealthy VolunteersNudix HydrolasesPolymorphism, GeneticPolymorphism, Single NucleotideEast Asian People

Stichwörter der Autor:innen

6-MPAZANUDT15TPMTpharmacokineticpolymorphisms

Substanzen

AzathioprineMercaptopurineMethyltransferasesNudix HydrolasesNUDT15 protein, humanPyrophosphatasesthiopurine methyltransferaseTPMT protein, human

Autor:innen und Institutionen

  • School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China.
  • The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou, China.
  • Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd, Hangzhou, China.
  • Zhejiang Aotuokang Pharmaceutical Group Inc. Co., Jinhua, Zhejiang, China.

ORCID-Profile: Ting Li

Zitieren

APA

Kong, Q., Zhang, Q., Chen, D., Lou, J., Zhu, J., Chen, M., & Li, T. (2024). Influence of TPMT and NUDT15 Genetic Polymorphisms on Mercaptopurine Pharmacokinetics in Healthy Volunteers. Genetic Testing and Molecular Biomarkers. https://doi.org/10.1089/gtmb.2023.0605

Vancouver

Kong Q, Zhang Q, Chen D, Lou J, Zhu J, Chen M, et al. Influence of TPMT and NUDT15 Genetic Polymorphisms on Mercaptopurine Pharmacokinetics in Healthy Volunteers. Genetic Testing and Molecular Biomarkers. 2024. doi:10.1089/gtmb.2023.0605

BibTeX
@article{Kong2024,
  author = {Kong, Qihui and Zhang, Qiqi and Chen, Di and Lou, Jinfang and Zhu, Jian and Chen, Mingjing and Li, Ting},
  title = {Influence of TPMT and NUDT15 Genetic Polymorphisms on Mercaptopurine Pharmacokinetics in Healthy Volunteers},
  journal = {Genetic Testing and Molecular Biomarkers},
  year = {2024},
  doi = {10.1089/gtmb.2023.0605}
}
Kostenlos starten →